Virulence Factors for Hemolytic Uremic Syndrome, Denmark

Emerging Infectious Diseases

Volumn 10, Issue 5, 2004, Pages 842-847

  Ethelberg, Steen ^a   Olsen, Katharina E P ^a   Scheutz, Flemming ^a,b   Jensen, Charlotte ^a   Schiellerup, Peter ^a   Engberg, Jørgen ^a   Petersen, Andreas Munk ^a   Olesen, Bente ^a   Gerner Smidt, Peter ^a   Mølbak, Kare ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

SHIGA TOXIN; VIRULENCE FACTOR;

AGE; BACTERIAL STRAIN; CHILD; CONFERENCE PAPER; DENMARK; DIARRHEA; EAE GENE; ESCHERICHIA COLI; ESCHERICHIA COLI O103; ESCHERICHIA COLI O157; GENE; HEMOLYTIC UREMIC SYNDROME; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; RISK FACTOR; STX2 GENE;

EID: 11144354536     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1005.030576     Document Type: Conference Paper

References (14)

1. Griffin PM, Mead PS, Sivapalasingam S. Escherichia coli O157:H7 and other enterohaemorrhagic E. coli. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, editors. Infections of the gastrointestinal tract. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 627-42.
2. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998;11:142-201.
3. Blanco J, Blanco M, Blanco JE, Mora A, Alonso MP, Gonzolez EA, et al. Epidemiology of verocytotoxigenic E. coli (VTEC) in ruminants. In: Duffy G, Garvey P, McDowell DA, editors. Verocytotoxigenic E. coli. Trumbull (CT): Food & Nutrition Press, Inc.; 2001:113-48.
4. Blom M, Meyer A, Gemer-Smidt P, Gaarslev K, Espersen F. Evaluation of Statens Serum Institut enteric medium for detection of enteric pathogens. J Clin Microbiol 1999;37:2312-6.
5. Konowalchuk J, Speirs JI, Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect Immun 1977;18:775-9.
6. Ørskov F, Ørskov I. Serotyping of Escherichia coli. Methods Microbiol 1984;14:43-112.
7. Friedrich AW, Bielaszewska M, Zhang WL, Pulz M, Kuczius T, Ammon A, et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 2002;185:74-84.
8. Beutin L, Zimmermann S, Gleier K. Human infections with Shiga toxin-producing Escherichla coli other than serogroup 0157 in Germany. Emerg Infect Dis 1998;4:635-9.
9. Eklund M, Leino K, Siitonen A. Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles. J Clin Microbiol 2002;40:4585-93.
10. Ostroff SM, Tarr PI, Neill MA, Lewis JH, Hargrett-Bean N, Kobayashi JM. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli 0157:H7 infections. J Infect Dis 1989;160:994-8.
11. Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, Gyles CL. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 1999;37:497-503.
12. Jenkins C, Willshaw GA, Evans J, Cheasty T, Chart H, Shaw DJ, et al. Subtyping of virulence genes in verocytotoxin-producing Escherichia coli (VTEC) other than serogroup O157 associated with disease in the United Kingdom. J Med Microbiol 2003;52:941-7.
13. Werber D, Fruth A, Buchholz U, Prager R, Kramer MH, Ammon A, et al. Strong association between Shiga toxin-producing Escherichia coli 0157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup 0157 in patients with haemolytic uraemic syndrome. Eur J Clin Microbiol Infect Dis 2003;22:726-30.
14. Safdar N, Said A, Gangnon RE, Maki DG. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. JAMA 2002;288:996-1001.